Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
December 27, 2005
Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?
Floris J Pos, Guus Hart, Christoph Schneider, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Patient-Reported Outcomes in the Acute Phase of the Randomized Hypofractionated Irradiation for Prostate Cancer (HYPRO) Trial
Felix Sinzabakira, Wilma D Heemsbergen, Floris J Pos, et al.
The Journal of Sexual Medicine
|
September 26, 2016
Sexual Function After Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer: Results From the Randomized Phase III HYPRO Trial
Ruud C Wortel, Floris J Pos, Wilma D Heemsbergen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 22, 2013
Hybrid registration of prostate and seminal vesicles for image guided radiation therapy
Johan de Boer, Marcel van Herk, Floris J Pos, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 18, 2009
Active inflammation in 18F-methylcholine PET/CT
Chau Le, Erik P van de Weijer, Floris J Pos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2021
Reply to I. R. Vogelius et al
Linda G W Kerkmeijer, Floris J Pos, Karin Haustermans, et al.
Frontiers in Oncology
|
April 30, 2020
Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
Wilma D Heemsbergen, Luca Incrocci, Floris J Pos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 21, 2018
Moderate Hypofractionation in Intermediate- and High-Risk, Localized Prostate Cancer: Health-Related Quality of Life From the Randomized, Phase 3 HYPRO Trial
Ruud C Wortel, Esther Oomen-de Hoop, Wilma D Heemsbergen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 9, 2004
Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer
Floris J Pos, Simon Horenblas, Joos Lebesque, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 7, 2006
Adaptive radiotherapy for invasive bladder cancer: a feasibility study
Floris J Pos, Maarten Hulshof, Joos Lebesque, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
International Journal of Radiation Oncology, Biology, Physics
|
December 27, 2005
Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?
Floris J Pos, Guus Hart, Christoph Schneider, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Patient-Reported Outcomes in the Acute Phase of the Randomized Hypofractionated Irradiation for Prostate Cancer (HYPRO) Trial
Felix Sinzabakira, Wilma D Heemsbergen, Floris J Pos, et al.
The Journal of Sexual Medicine
|
September 26, 2016
Sexual Function After Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer: Results From the Randomized Phase III HYPRO Trial
Ruud C Wortel, Floris J Pos, Wilma D Heemsbergen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 22, 2013
Hybrid registration of prostate and seminal vesicles for image guided radiation therapy
Johan de Boer, Marcel van Herk, Floris J Pos, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 18, 2009
Active inflammation in 18F-methylcholine PET/CT
Chau Le, Erik P van de Weijer, Floris J Pos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2021
Reply to I. R. Vogelius et al
Linda G W Kerkmeijer, Floris J Pos, Karin Haustermans, et al.
Frontiers in Oncology
|
April 30, 2020
Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
Wilma D Heemsbergen, Luca Incrocci, Floris J Pos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 21, 2018
Moderate Hypofractionation in Intermediate- and High-Risk, Localized Prostate Cancer: Health-Related Quality of Life From the Randomized, Phase 3 HYPRO Trial
Ruud C Wortel, Esther Oomen-de Hoop, Wilma D Heemsbergen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 9, 2004
Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer
Floris J Pos, Simon Horenblas, Joos Lebesque, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 7, 2006
Adaptive radiotherapy for invasive bladder cancer: a feasibility study
Floris J Pos, Maarten Hulshof, Joos Lebesque, et al.
Page
of 9